Not yet recruitingInterventionalNot ApplicableLast updated Jan 24, 2025

ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

Feasibility of Blood-based Test for Multi-cancer Early Detection in Asymptomatic Screening Population（ProSight）: a Multi-centre Interventional Study

Overview

ClinicalTrials.gov ID: NCT06790355
Lead Sponsor: Shanghai Weihe Medical Laboratory Co., Ltd.INDUSTRY
Brief Summary: This is a prospective, multi-centre interventional study evaluating the feasibility of blood-based multi-cancer early detection test in asymptomatic screening cohort.
Study Type: Interventional

Status

Overall Status: Not yet recruiting
Start Date: Mar 1, 2025Estimated
Primary Completion Date: Dec 31, 2026Estimated
Completion Date: Dec 31, 2026Estimated

Study Record Dates

First Submitted: Jan 12, 2025
First Submitted that Met QC Criteria: Jan 16, 2025
First Posted: Jan 24, 2025Actual
Last Update Submitted that Met QC Criteria: Jan 16, 2025
Last Update Posted: Jan 24, 2025Actual
Last Verified: Jan 2025

NCT07598747Recruiting

Prospective Study for the Development, Validation and Confirmation of a Multi-Cancer Early Detection Platform Through Whole-Genome Sequencing Analysis of Circulating DNA in Cancer and Non-Cancer Subjects

NCT06217900Recruiting

a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND）

NCT06231953Recruiting

A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers

NCT04820868Completed

The Unintrusive Detection of EaRly-stage Cancers

NCT05633342Unknown status

Project CADENCE (CAncer Detected Early caN be CurEd)

NCT06036563Unknown status

Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing